STOCK TITAN
  1. Home
  2. News
  3. GMED

Globus Medical Inc - GMED STOCK NEWS

Welcome to our dedicated news page for Globus Medical (Ticker: GMED), a resource for investors and traders seeking the latest updates and insights on Globus Medical.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Globus Medical's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Globus Medical's position in the market.

News
Globus Medical Reports Fourth Quarter and Full Year 2023 Results
Rhea-AI Summary
Globus Medical, Inc. (NYSE: GMED) reported strong financial results for Q4 2023 and full year 2023, with record worldwide net sales. The merger with NuVasive has been successful, driving growth and enhancing customer service. The company remains focused on innovation, product launches, and merger integration. Despite a decrease in GAAP net income for Q4 2023 due to acquisition costs, non-GAAP net income increased. The company reaffirmed its 2024 revenue guidance range and earnings per share expectations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.55%
Tags
earnings
-
News
Globus Medical Schedules Fourth Quarter and Full Year 2023 Earnings Release and Conference Call
Rhea-AI Summary
Globus Medical, Inc. (GMED) will release its financial results for Q4 and full year 2023 on February 20, 2024. The company will host a teleconference to discuss its performance with investors. Participants can join via webcast or telephone.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.15%
Tags
earnings
-
News
Globus Medical promotes Keith Pfeil to Chief Operating Officer and Chief Financial Officer
Rhea-AI Summary
Globus Medical, Inc. (NYSE: GMED) has promoted Keith Pfeil to the role of chief operating officer (COO) and chief financial officer (CFO) to drive the company's strategic roadmap through business and operational planning and financial performance management. Pfeil will oversee all day-to-day operational activities and financial activities, representing the organization to external stakeholders. The company expects to announce its fourth quarter and full year 2023 financial results on February 20, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.44%
Tags
none
News
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
Rhea-AI Summary
Globus Medical, Inc. (NYSE: GMED) anticipates fourth quarter 2023 sales of approximately $615.5 million, an increase of 124.2 percent over the fourth quarter 2022. Full year 2023 sales are expected to be approximately $1.567 billion, an increase of 53.2 percent over the prior year. The company is well positioned for future growth drivers in the broader musculoskeletal market and has established its full year 2024 revenue guidance range of $2.450 billion to $2.475 billion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.25%
Tags
earnings
-
News
Globus Medical Reports Third Quarter 2023 Results
Rhea-AI Summary
NYSE: GMED - Globus Medical Announces Strong Q3 2023 Financial Results and Raises 2023 Revenue Guidance to $1.55 Billion
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.69%
Tags
earnings
-
News
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
Rhea-AI Summary
Globus Medical, Inc. will announce its financial results for Q3 2023 on November 7. A teleconference will be held to discuss performance with the investment community.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.34%
Tags
earnings
News
Five-Year Study Outcomes of the NuVasive Simplify Cervical Disc were Presented at the North American Spine Society 38th Annual Meeting
Rhea-AI Summary
Globus Medical presents positive five-year outcomes from the NuVasive Simplify Cervical Disc study, demonstrating long-term clinical success and superiority over ACDF procedural outcomes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.24%
Tags
none
-
News
Twenty Years of the NuVasive XLIF Procedure Celebrated at the Society for Minimally Invasive Spine Surgery 2023 Annual Forum
Rhea-AI Summary
Globus Medical celebrates twenty years of the NuVasive XLIF procedure at SMISS '23 Annual Forum.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.38%
Tags
none
-
News
Globus Medical and NuVasive to Sponsor and Participate at EUROSPINE 2023
Rhea-AI Summary
Globus Medical continues partnership with EUROSPINE and will attend EUROSPINE 2023. They will showcase their musculoskeletal solutions at various conferences in Q4 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.93%
Tags
none
News
NuVasive Specialized Orthopedics Launches Precice Bone Transport in International Markets
Rhea-AI Summary
Globus Medical launches Precice Bone Transport system in select markets, positively impacting over 250 trauma and oncology patients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.79%
Tags
none
Stock GMED logo
Globus Medical Inc

NYSE:GMED

GMED Rankings

#1235 Ranked by Market Cap
#3949 Ranked by Stock Gains
N/A Ranked by Dividends

GMED Stock Data

6.99B
111.92M
0.79%
96.92%
5.73%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States
Audubon

About GMED

globus medical, inc. is a leading musculoskeletal implant manufacturer and is driving significant technological advancements across a complete suite of spinal products. founded in 2003, globus’ single-minded focus on advancing spinal surgery has made it the fastest growing company in the history of orthopedics. globus is driven to utilize superior engineering and technology to achieve pain free, active lives for all patients with spinal disorders. additional information can be accessed at www.globusmedical.com.